A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0,5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance - Pflugfelder, S C; Maskin, S L; Anderson, B (Am J Ophthalmol, 2004)
et al.